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1 Introduction
Since 2000, the world has seen a general decline in the rate of malaria transmission. Through
benchmarks, such as the Millennium Development Goals, and programs, such as Roll Back Malaria
(RBM), malaria mortality rates dropped by 42 percent between 2000 and 2012. This is in line
with meeting the WHO targets for malaria, which is a 75 percent reduction by 2015 (Tuschman,
2013). However, recent developments are threatening to undo this progress. For example, it has
been well-documented that malaria is sensitive to weather variations and climate change (Bouma
& Kaay, 1996). This implies that the risk of malaria transmission may increase with climate
change in certain regions (Patz et al. , 2002; McMichael et al. , 2006), as also reported by the
Intergovernmental Panel on Climate Change (IPCC, 2014).
In order to design effective policies against malaria, cost-benefit analysis (CBA) helps in eval-
uating alternative courses of action (Mills et al. , 2008). This paper focuses on the benefits of
reduced malaria incident rates. Willingness to pay is a measure of the monetary value of the
utility differential caused by an alternative health state (Brouwer & Bateman, 2005). We focus on
the willingness to pay for reduced malaria morbidity.
The valuation literature has seen a surge in studies that measure WTP to avoid or treat various
diseases, including malaria. For malaria, WTP studies can be found from 1993 (Weaver et al. ,
1993) until the present (Aleme et al. , 2014). An effective method of summarizing these studies is
to systematically analyze their results in a meta-analysis. Meta-analysis is a statistical approach
to synthesize the main findings from different studies focusing on a similar phenomenon or target
variable, and identifying sources of variation in their measurement (Van Houtven, 2008). In this
case, we focus specifically on the measurement of WTP to avoid or treat malaria. A meta-analysis
has the distinct advantage in that it avoids potential researcher selection bias when one summarizes
measurements across the literature. Additionally, meta-analysis facilitates the transfer of benefit
values across different settings (Brouwer, 2000).
The literature concerning WTP to avoid malaria morbidity has already been summarized by
Trapero-Bertran et al. (2012). Our study builds upon that existing study and adds to it in a
number of ways: We extend the database with other studies, add new explanatory factors, and
improve the econometric framework. Our main objective is to explain the differences in average
WTP to avoid morbidity risk due to malaria, using a meta-analysis.
The average WTP value from the individual malaria valuation studies is the dependent vari-
able. Using regression analysis, we examine to what extent methodology-related (e.g. revealed
preferences versus stated preferences), sample population-related (e.g. age, income) and policy-
related (e.g. specific treatment) explanatory variables have a systematic impact on WTP to avoid
malaria morbidity.
The rest of the paper is organized as follows: Section 2 provides an overview of the methodology
and previous meta-analyses, Section 3 explains the data collection procedure, Section 4 summarizes
the data, Section 5 presents the analysis and Section 6 concludes.
2 Meta-Analysis
2.1 Methodology
A meta-analysis aims to systematically describe empirical findings. A number of publications give
guidelines to constructing datasets and analyzing them (Stanley, 2001; Smith & Pattanayak, 2002).
We follow Van Houtven (2008) and Nelson & Kennedy (2009). Nelson & Kennedy (2009) reviews
140 published valuation meta-analyses in terms of five aspects: (i) sample selection criteria, (ii)
basic data summary, (iii) primary data heterogeneity, (iv) treatment of heteroskedasticity and (v)
robustness checks. Van Houtven (2008) describes how these aspects should be applied to datasets
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when the variable of interest is WTP for health outcomes.
The sample selection criterion is concerned with author or publication bias occurring during
the creation of the dataset. If the researcher is getting studies through citations in a few papers,
then the dataset may be biased in favor of published or publishable results. When collecting data,
there must be a standard search process that prevents such biases from occurring. This involves
explicitly specifying the keywords and databases searched, along with how articles are selected.
Out of the 140 meta-analyses, only 61 mention a selection criteria (Nelson & Kennedy, 2009).
In health valuation this is of particular importance, since there is relatively little uniformity in
research techniques across studies. A broad selection criterion may give too many different studies
to compare. On the other hand, a restrictive selection criterion may give too few studies for a
meaningful analysis (Van Houtven, 2008).
The basic data summary category is concerned with the explanation of the dataset itself. As
in any empirical study, descriptive statistics and scatter plots of key variables help strengthen
its validity. In a meta-analysis, since each observation carries a standard error with it, these
standard errors can be weighted when making descriptive calculations. Standard errors are also
used as weights in regressions (Van Houtven, 2008). Additionally, these weights allow for more
accurate descriptives to be presented. This is not a common practice in economics papers, but it
is in medicine meta-analyses. Hence only 14 of the 140 meta-analyses report weighted statistics
(Nelson & Kennedy, 2009).
Primary data heterogeneity occurs because the observations come from different studies. This
implies that each observation carries some (un)observed characteristic of the particular study from
which it was drawn. Regression models aim to control for this heterogeneity. Being able to account
for this heterogeneity, one can explicitly show how (and perhaps why) empirical results of the same
nature differ from study to study (Van Houtven, 2008). Thirty-three of the 140 meta-analyses make
use of OLS models that do not account for between-study heterogeneity (Nelson & Kennedy, 2009).
Since observations are subject to heterogeneity, this means that the resulting variance of resid-
uals is not constant across observations. In other words, the regression model may suffer from het-
eroskedasticity. If one controls for heterogeneity, then this should not be a problem (Van Houtven,
2008). It is also possible to approach this problem via robust or clustered standard errors. Robust
standard error algorithms, such as the Huber-White estimator (White, 1980), are sufficient to deal
with heteroskedasticity. Interestingly however, 46 of the 140 studies do not treat heteroskedasticity
in their regression framework (Nelson & Kennedy, 2009).
The final aspect of evaluation is robustness checks. Robustness checks in applied econometrics
are considered a “tenth commandment” (Kennedy, 2002). This can be done by implementing
different functional specifications in regressions (Van Houtven, 2008), excluding outliers and alter-
nating regression models (Nelson & Kennedy, 2009). However, in the 140 papers that are reviewed
by Nelson & Kennedy (2009), only 41 mention outliers; and of these 41, only 16 report a residual
analysis. There is no mention of different functional forms (Nelson & Kennedy, 2009).
With these issues in mind, we build a valid regression model. The “first port of call” in meta-
regression models is the WLS (Nelson & Kennedy, 2009). The WLS is a case of the OLS where
the residual variance is assumed to differ across observations. In principle, this difference is due
to an observed statistic. All other assumptions of the OLS, such as the independence of the error
on explanatory variables, do not change. Hence, the function (in a simple case) can be:
yk = β0 + β1x1k + β2x2k + β3x3k + k (1)
Where k is an individual observation and k ∼ N(0, σ
2

wk
), wk being the cause of heteroskedas-
ticity across observations. In our case, this is a study-specific variable, such as sample size. If this
is true, then Equation 1 is efficient and gives unbiased coefficients. Determining wk, especially
for WTP observations, is not trivial. Standard practice is to use the standard error of each mean
WTP observation as wk. However, nothing is claimed about the heterogeneity across studies in
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this case. Here too, we make the claim that all heterogeneity information is stored in the standard
errors, although this may be too restrictive (Van Houtven, 2008).
If we want to analyze study effects, then we add in study dummies in Equation 1. A more
systematic way of doing this is to assume that all studies are panels and then employ a panel
model. With this, Equation 1 is expanded to:
yjk = β0 + β1x1jk + β2x2jk + β3x3jk + µj + jk (2)
The study index is denoted by j. Hence, observation k is found in study j. Here we assume
jk ∼ N(0, σ2 ), which is independent across explanatory variables and µj . Since we know that
study heterogeneity exists, the panel effects term (µj) is considered to be random. Thus, µj ∼
N(0, σ2µ) and σ
2
µ is the random effects coefficient. In principle, Equation 2 is sufficient to explain
study heterogeneity. The Hausman test (Hausman, 1978) can be employed to see if this effect is
significant and, hence, random or fixed.
Note that the information on standard errors of mean WTP is now assumed to be in the random
effects coefficient. The information of the standard errors can be incorporated by a weighting
scheme. In Equation 2, we now assume jk ∼ N(0, σ2j ). This new variance term, which changes
across studies, is dependent on the standard error of mean WTP. In other words, we account for
study-level differences and weighting of mean WTP. This is the model used in Trapero-Bertran
et al. (2012).
This specific random effects model is sufficient to solve problems associated with meta-regressions.
We control for study heterogeneity and the resulting heteroskedasticity. However, we are bounded
by only having one level of grouping. In the random effects model, the µi variable is an addition
to the constant term β0, not the slope coefficients. What if observations are grouped into stud-
ies but studies are grouped in authors or countries? This requires accounting for grouping at a
higher level. Additionally, what if we want to explicitly observe differences between groups using
group-level variables? This means assuming that slope coefficients are random as well.
The mixed effects specification addresses both issues simultaneously. We expand Equation 2
to include an additional grouping level and random effects across explanatory variables:
yijk = β0 + β1x1ijk + β2x2ij + β3x3i + µi(x3i) + µi + µij(x2ij) + µij + ijk (3)
Authors or countries are denoted by the index i. Hence, observation k is found in study j
which was conducted in country or written by author i. Naturally, each study must have occurred
in one country. Note that the x1 series changes at the observation level. This is contrary to x2
and x3 which change at the study and author/country levels. µi and µij are random effects across
the groups, which affect the constant term β0. Similarly, µij(x2ij) and µi(x3i) are random effects
across the variable series x2 and x3 respectively. They describe how the β2 and β3 slope coefficients
change across groups. The error term has the standard assumption of ijk ∼ N(0, σ2 ). All random
effects are assumed to be independent of the error term and each other (Konstantopoulos, 2006).
Equation 3 provides a flexible framework where the sources of heterogeneity and heteroskedas-
ticity can be examined. If we know that study and author/country level variables are causing
non-constant variance in the residuals, then we can account for these by adding in random effects.
At the same time, we are able to capture any additional heterogeneity that may occur at levels
other than the study. The strength of the model comes from its explanatory potential. While
Equation 2 (and to some degree Equation 1) provides reliable output, they lack in explanation.
Thus, we use the mixed effects model as our main regression specification.
In principle, the coefficients in Equation 3 are clean of any study and author/country effects.
Therefore, we are able to utilize them in predicting the mean WTP to avoid malaria morbidity
in other settings. This idea is the driving force behind benefit transfers: the benefit of avoiding
malaria in a new policy setting can be estimated with the above-mentioned regression analysis
(Kaul et al. , 2013).
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2.2 Existing Disease Valuation Meta-Analyses
Meta-analyses on the morbidity valuation of specific diseases are fairly recent. Before, there were
many studies on WTP to avoid/reduce morbidity itself. For example, Johnson et al. (1997) present
a meta-analysis on how morbidity duration and severity impact valuation. WTP to avoid short-
term morbidity is chosen as the variable of interest and is regressed on a health state index. After
adjusting for between-study heterogeneity, the authors find that WTP is positively affected by
severity and length of morbidity. Another example is Van Houtven et al. (2006), which conclude
that WTP increases with duration but less than proportionally so.
Trapero-Bertran et al. (2012) present a meta-analysis on WTP for malaria treatment. All
mean WTP figures are converted to 2011 US Dollars. Although they have 59 studies, only 24
of them report standard deviations, which are used for calculating weighted WTP values in the
analysis. The regression model is a random effects model where the observations are weighted by
their standard error and the panel is identified by study. Mean WTP is regressed on variables
regarding the study design, location, policy and country-average GNI per capita. The regression
results are checked for robustness by running the same specification on the same variables minus
sample properties (rural/urban, years of education and country).
They conclude that mean WTP to avoid malaria increases with GNI per capita and is sensitive
to the elicitation method used. Trapero-Bertran et al. (2012) underline the lack of data in malaria
WTP studies. One particular concern is the inclusion or exclusion of true zero WTP values in the
average reported WTP. They implicitly link the heterogeneity across studies to the fact that crucial
information regarding the calculation of estimated WTP is often left out in study descriptions.
2.3 Contributions of this Study to the Existing Literature
This study advances Trapero-Bertran et al. (2012). Our advancement is fourfold: database
extension, definition of explanatory variables, modelling framework and results.
We cleaned the database of Trapero-Bertran et al. (2012). We identified multiple studies that
make use of the same dataset and report the same results. Some results were reported in a working
paper and then a journal article. Sometimes, the same results were used to underline a different
phenomenon. We accounted for this by cross-checking survey location and data years between
studies with the same authors. If the location and year matched, then the studies were screened
to determine whether or not the same dataset had been used.
We also added new explanatory variables. We include household income, payment frequencies,
respondents’ age and altruistic policies. In addition to this, we also include revealed preference
studies, whereas Trapero-Bertran et al. (2012) only focused on stated preferences.
We used PPP-adjusted values rather than exchange rate adjusted values as in Trapero-Bertran
et al. (2012). This is because most studies in the database were conducted in rural areas of
developing countries. Hence, the households’ purchasing power is most likely not reflected in the
official currency market. Using exchange rate conversion would underestimate the actual WTP
in dollar terms; hence we use PPP conversion for a better comparison. The same conversion
procedure is used for household income.
Trapero-Bertran et al. (2012) use prevention and treatment interchangeably in the regression
analysis. We do not, and check if there is a difference.
We employ a mixed effects model and compare it to other models that are its special cases (WLS
and weighted random effects). We test which model variant fits best, and run further specification
tests. Trapero-Bertran et al. (2012) omits this, even though meta-regressions are prone to be
sensitive to model specification (Nelson & Kennedy, 2009).
We try to replicate the results from Trapero-Bertran et al. (2012) and add new ones, taking
our hypotheses based on the morbidity valuation and other economic valuation literature.
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3 Data Collection Procedure
In collecting the data, an extensive literature search was conducted using Google Scholar, EconLit,
IngentaConnect, JSTOR, PubMed and Web of Science databases. Five sets of keywords were
utilized: “Willingness to Pay Malaria”, “Contingent Valuation Malaria”, “Revealed Preferences
Malaria”, “Economic Valuation Malaria” and “Stated Preferences Malaria”. More often than not,
a typical search returned more than 100 studies at a time. In Google Scholar, only the first 10
pages of results were considered (10 results per page). In other databases, the maximum number
of articles considered per search result was 200.
80 papers were selected and 78 of them downloaded. The remaining two papers were identified
by the search but were not accessible1. Emails were sent to the authors requesting the papers, but
no reply was received, also not after sending reminders.
Twelve papers were eliminated because WTP was not estimated, and five did not report it. In
five cases, the same study had been downloaded multiple times (working paper, technical report,
journal publication etc.). The final publication version was used. In another case, the same WTP
for the same treatment policy from the same sample was used in different papers by the same
authors. These too were discarded to avoid double-counting. However, WTP for different policies
were treated as separate observations even when based on the same survey.
A total of 55 papers remained (see Table A2 in appendix). Some of the eliminated studies were
included in the analysis presented in Trapero-Bertran et al. (2012), so we cannot replicate their
results.
Out of these 55 studies, 192 mean WTP values were extracted. Four of these values (Lertma-
harit et al. , 2000) could not be used, because the date of the data collection is not specified.
4 Data Summary
4.1 Mean WTP to Avoid Malaria Morbidity
Since avoiding malaria can be avoided in many ways (bednets, health-care, pesticides etc.) with
different payment frequencies, standardization is crucial. Every WTP and monetary figure is
expressed in 2012 international US dollars (calculated with the Geary-Khamis method). The PPP
conversion factor and GDP deflator data are taken from the World Bank. WTP is converted into
a value per product or service offered. That is, if a paper reports a mean WTP of 100 dollars
for 2 pesticide programs, the number is divided by 2. In some WTP studies, respondents were
asked for one-off payments, but we interpret these as repeat payments if the impact is transient.
For example, we assume that payments for a malaria vaccine which is effective for 2 years only is
renewed every two years. Payments for an indefinite vaccine are treated as a one-off payment. We
use dummies for monthly, quarterly, yearly and one-off payments. We assume that payments are
one-off, unless stated otherwise. Trapero-Bertran et al. (2012) did not standardize stated WTP
values and so our results are hard to compare to theirs.
4.2 Key Explanatory Variables
The key explanatory variables were selected according to what was found in the morbidity, mor-
tality and environmental valuation literature:
• Income: more income implies a higher WTP value (Asafu-Adjaye & Dzator, 2003; Onwujekwe
et al. , 2006; Udezi et al. , 2010). Additionally, we expect an inelastic relationship between
income and mean WTP (Bosello et al. , 2006).
1Legesse et al. (2007) and Adepoju et al. (2012).
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• Revealed Preferences: WTP is reported to differ between revealed preferences and stated
preferences (Kennedy, 2002). People may overstate their WTP (Bateman et al. , 1995).
Hence, we expect a lower WTP if revealed preferences are used.
• Elicitation Method: Different methods often produce different values of WTP, with discrete
choice methods producing higher values than open-ended questions or payment cards (Bate-
man et al. , 1995). For an explanation of all CV elicitation methods used, see Table A1 in
appendix.
• Payment Frequency: One-off payments result in higher mean WTP values than annual pay-
ments (Loomis & White, 1996) and monthly payments yield a higher WTP than annual
payments (Spaninks & Hoevenagel, 1995; Pearce et al. , 2002).
• Inclusion of Zeros: Studies sometimes do not include true zero WTP values into the calcula-
tion of mean WTP. Trapero-Bertran et al. (2012) took this into consideration, but did not
find a significant effect.
• Nigeria: More than half of our observations are from Nigeria, which was also the case for
Trapero-Bertran et al. (2012).We therefore include a Nigeria dummy in the regression anal-
ysis.
• Treatment: We compare prevention and treatment. There are two approaches. The first
stems from the health-state expected utility theory. Here, utility functions satisfy the von
Neumann-Morgenstern axioms and their parameters vary between health states (Arrow, 1974;
Viscusi & Evans, 1990). The WTP value deriving from this framework does not account for
the method of going from one health state to another. For example, a treatment that has a
90% likelihood of success and a prevention that has 90% effectiveness have identical WTPs,
since the final expected outcomes are the same (“healthy” utility with 90% probability).
The second approach considers individuals being biased in their projection of different utility
states. A healthy agent is more likely to over-project the loss of utility due to being sick,
whereas a sick agent possibly under-projects the gains from being healthy. The healthy
agent can be over-projecting due to loss aversion and the sick agent can be under-projecting
because they have adapted to being sick (Loewenstein et al. , 2003; Dolan & Kahneman,
2008). Under this approach, the above-mentioned prevention should have a higher WTP
than the treatment policy.
• Control: The WTP for reductions of mortality risk changes with the perception of control.
For example, WTP for reducing car accident death probability is less than WTP for reducing
the risk of dying from bronchitis (Viscusi & Huber, 1987; Viscusi et al. , 1991). We test
whether the locus of control affects WTP, distinguishing between private and community
interventions.
• Age: Age has a non-linear impact on mortality valuation, for reasons that are still under
discussion (Krupnick, 2007).
• Altruism: We define altruistic policies as those that have a benefit to the surrounding house-
holds. Thus, we expect free-riding to occur and hypothesize altruistic policies to be valued
less than other policies.
• Publication Type: We test for differences between mean WTP values across different types
of publications.
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Table 1 lists our variables of interest and compares them to what has been tested in Trapero-
Bertran et al. (2012). There is some common ground, but we add and take away from their
variable list. For example, we do not include rural/urban and years of education. This is because
we have included the household income variable. Education is not included because the data is
too noisy. Some papers give years of education, others indicators or dummies (e.g. literacy).
One important variable of interest is the effectiveness of each policy. This is not included
because not all papers reported the effectiveness rate of their proposed interventions. We attempted
to gather effectiveness information from external sources. However, the gathered data was too few,
making a regression analysis non-viable. Therefore, we leave out the effectiveness of each policy of
our database.
Table 1: Explanatory Variables
This Paper Trapero-Bertran et al. (2012)
Policy
Altruism
Control (Goods & Services)
Payment Frequencies
Treatment Treatment
ITNs
Other Prevention
Sample
Nigeria Nigeria
Inclusion of Zeros Inclusion of Zeros
Household Income GNI per Capita
Respondent Age
Rural
Rural or Urban
Years of Education
Methodology
CV Elicitation Method CV Elicitation Method
Publication Type
Revealed Preferences
4.3 Descriptive Statistics
Table 2 gives an overview of differences in mean WTP across subgroups.From left to right first
the statistics weighted by standard errors are presented, followed by the non-weighted statistics.
Although the weighted statistics are lower, a glance at the confidence intervals shows that this
difference is not significant at the 5 percent level. The weighting produces more consistent statistics,
since information regarding study effects is incorporated. Table A3, in the appendix, gives all
summary descriptives.
The overall mean WTP is close to 40 US Dollars per year (2012, PPP). This number is not
statistically different from the mean WTP for only one-off policies. There is some preliminary
support for our hypotheses. Mean WTP is significantly higher for private interventions for public
and community interventions. Altruistic mean WTP is much lower than overall mean WTP, again
in line with our hypothesis. Treatment and prevention valuations are different with prevention
showing higher valuation results.
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Table 2: What is the Overall Mean WTP?
Weighted Unweighted
Mean WTP Lower CI Upper CI Mean WTP Lower CI Upper CI N
Private (Goods) 37.987 36.396 39.578 52.010 38.201 65.818 144
Public (Services) 26.121 24.712 27.530 164.413 -5.899 334.725 44
Treatment 32.224 28.148 36.301 160.148 -45.915 366.211 36
Prevention 42.963 40.898 45.029 57.189 41.907 72.471 138
One-Off Payment 36.218 33.738 38.699 118.094 25.434 210.754 81
Annual Payment 36.159 34.328 38.283 40.480 33.245 47.714 89
Altruistic 9.687 8.498 10.876 45.294 -22.149 112.738 23
OVERALL 39.509 37.680 41.339 78.317 37.671 118.963 188
5 Analysis
5.1 Replication of Trapero-Bertran et al. (2012)
We adjusted some data in order to replicate the results presented in Trapero-Bertran et al. (2012).
We make monetary conversions by exchange rate, choosing 2012 as the target year (as opposed to
2011 in the previous study). We still keep the per policy conversion, which was not done in the
previous study. Also, we omit the double counts from our analysis, which is also different from the
previous study.
Table 3 gives the replication output, where the reduced and extended models are in line with
the specification in the previous study. The regression model is the weighted random effects model,
as shown in Equation 2. We also include the regression results from Trapero-Bertran et al. (2012).
We largely fail to replicate the results reported in Trapero-Bertran et al. (2012). One result
that we successfully reproduce include insecticide-treated nets being valued higher than other
prevention goods or methods. Another is that the open-ended CV elicitation method yields lower
WTP values than the bidding game method.
Although the databases are different, this underlines how sensitive results can be, especially in
meta-analyses (Nelson & Kennedy, 2009) and motivates the importance of conducting sensitivity
analyses and subjecting the model to different regression specifications.
5.2 Main Regressions
Table 4 gives the output of our regression analysis. Columns 1 and 2 are the WLS and weighted
random effects models, respectively. Both regression models are weighted by the standard error of
the mean WTP statistic. Column 3 presents the mixed effects model. It accounts for study and
author effects, nullifying the need to weigh observations by standard errors. Column 4 presents the
outcome of the mixed effects model without residual outliers. An outlier is defined as being more
than two standard deviations away from the mean residual (Bellavance et al. , 2009). Both columns
3 and 4 have coefficients that have standard errors calculated by the Huber-White estimator to
control for heteroskedasticity (White, 1980). In short, one can think of column 3 as giving the
main results and the other columns testing these results under different model specifications.
A finding is consistent if we observe it throughout all the columns in Table 4. This means
that the result is robust to different model specifications. We discuss the results from the mixed
effects regression (column 3). The range of the coefficient, from the other models, is given in the
parentheses.
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• Income: The income elasticity is the coefficient of the income variable, since we use a log-log
specification. The income elasticity is 0.52 (0.29 - 0.52), implying that a 1 percent increase
in household income, ceteris paribus, will lead to a 0.52 percent increase in mean WTP to
avoid malaria morbidity. This validates global climate change models that assume income
elasticity for vector-borne diseases, such as malaria, to be less than 1 (Tol & Heinzow, 2003;
Bosello et al. , 2006).
• Age: As expected, the impact of age is non-linear. The regressions show that people above
the age of 31.32 (30.73 - 48.07) have increasing WTP with each passing year. Before this
cut-off, the marginal impact of age is negative. The age variable ranges from 24 to 58, with
an average of 40. Hence, most of our sample is above, or close to, the cut-off. This is in
support of the VSL literature findings (Krupnick, 2007). To see an illustration of the impact
of age, and a justification of the linear and logarithmic specification, see Figure 1 in the
appendix to this paper.
• Altruism: The coefficient on the altruism dummy is -0.84 (-0.84 - -1.40). This indicates
that altruistic policies, on average are valued 56.9% (56.9% - 75.3%) less than non-altruistic
policies. This suggests that agents may free-ride on public goods, reflected in the decrease
of mean WTP.
• Revealed Preferences: The coefficient of the revealed preferences dummy is -1.70 (-1.53 - -
3.30). This indicates that revealed preference studies, as opposed to stated preference studies
produce 81.8% (78.3% - 96.4%) lower WTP values. This result should be approached with
caution, since we only have one study (Hoffmann et al. , 2009) that uses revealed preferences
data.
• Payment Frequencies: Mean WTP for annual payments is, as expected, lower than one-off
payments. We find no consistent impact of monthly and quarterly payments. Annual pay-
ments lower mean WTP by 58.4% (48.5% - 58.4%). This is consistent with the environmental
valuation literature findings, indicating that respondents discount future benefits (Loomis &
White, 1996; Pearce et al. , 2002).
We find no consistent differences between treatment and prevention. Although we have sig-
nificant treatment coefficients in some regression models, these are not consistent throughout the
entire analysis. Indeed, the difference is negative in some specifications and positive in others. We
find similar inconsistent results for the inclusion of zeros, if the study was carried out in Nigeria,
goods instead of services and if the publication was a technical report instead of a journal article.
Although the mixed effects regression is put forward as the most preferable specification due to
its flexibility, this is not enough to declare it as a strictly superior model. In order to compare the
regression models, we apply another metric, namely its predictive power. Therefore, if a model is
‘better’ than another one, this means that is more suitable for using in predictions. A numerical
comparison is done in the next subsection.
5.3 Comparison of Model Predictive Power
We perform an out-of-sample test as a cross-validation exercise (Osborne, 2000). To the best of our
knowledge, this is the first implementation in the meta-analysis literature. The cross-validation
exercise is done as follows. A random 80 percent of the sample is taken and the regressions from
Table 4 are re-run. The result of these regressions are then used to predict the mean WTP values
of the remaining 20 percent of the sample. Then, the standard error of prediction is calculated, as
such:
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σp =
√∑
i∈N (Yi − Yˆi)2
N
Where N is the size of the test sample. Yi denotes the observation while Yˆi denotes the
predicted value. Therefore, a lower σp constitutes a higher predictive power. This is similar to the
leave-one-out test done in many meta-analyses (e.g. Brander et al. (2012)).
For each regression model, this exercise was repeated 10,000 times in order to get a distribution
of the σp for each model. Before every run, the control (80 percent) and test samples are determined
randomly. A variable, which changes across observations with the uniform distribution between 0
and 1, is created for all observations. All observations below 0.1 or above 0.9 are considered the
test sample, while the others are considered the control sample. Once the σp is calculated and
stored, the variable with the uniform distribution is deleted, re-created and the process is repeated.
In Table 5, we can see the distribution of standard prediction error (σp) per model, along with
some distribution statistics.
Table 5: Cross-Validation Results Across Model Specifications
Model WLS Weighted Random Effects Mixed Effects
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Average σp 0.940 0.049 0.472
Std Deviation 0.473 0.078 0.144
Minimum σp 0.142 0.0004 0.093
Maximum σp 12.952 2.412 1.444
At first glance, the weighted random effects outperforms the mixed effects in terms of predictive
power. The average standard error of prediction is smaller by an order of 10 (0.049 versus 0.472).
However, the maximum σp calculated with the mixed effects is almost half the one for the weighted
random effects (2.412 versus 1.444). Hence, mixed effects does better in minimizing the maximum
error made. For conducting benefit transfers, the test statistic suggests that the weighted random
effects model is more suitable than the other models.
Even though the mixed effects does better in terms of model flexibility, as shown in Section 2,
and in minimizing the maximum prediction error. The weighted random effects model does better
in minimizing the overall prediction error.
6 Conclusion and Discussion
Our main research focus is to see what explains mean WTP to avoid morbidity risk due to malaria.
The research question implies looking only at malaria prevention, but we look at malaria treatment
as well. We improve the analysis, with respect to the initial study (Trapero-Bertran et al. ,
2012), by using better data, having stricter variable definition standards, implementing a more
comprehensive regression analysis and reaching new conclusions.
Our overall contribution can be split into four parts. We make use of more variables in the
database and make sure to eliminate double-counts. By using a more detailed database, we control
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for important variables of interest and reduce potential omitted variable bias. This includes PPP
conversions, payment frequency dummies and identifying potential pre or post morbidity differences
in valuation. We consider the sensitivity of results in meta-regressions as an issue (Nelson &
Kennedy, 2009) and hence use different regression specifications, robustness checks and cross-
validation. Lastly, we find consistent results, of which some are new to the morbidity literature,
in particular the impact of age on mean WTP and lower mean WTP for altruistic policies rather
than privately consumed goods.
We hypothesize that income will have a positive effect, while revealed preferences and having
more frequent payments will have negative effects. These three hypotheses are supported by the
regression analysis. Additionally, Nigeria and the inclusion of zero WTP values are shown to have
no impact, confirming the findings in Trapero-Bertran et al. (2012).
Differences across CV elicitation methods are not observed consistently. This is unexpected,
since different CV elicitation methods are known to give different results (Bateman et al. , 1995).
If we observe a significant effect with less residual noise, this indicates that the true effect might
not be detected in the other models due to high residual variance. This explanation is supported
by our small sample size. The literature suggests there are differences, but our sample size may
not be big enough to detect them.
We also add new hypotheses based on mainstream economics and the mortality literature.
One of these hypotheses is that age has a non-linear impact on mean WTP. This hypothesis finds
support in the fact that the regressions show a consistent non-linear impact of age on mean WTP.
The positive portion of this impact, valid for people above 30 years of age, is under discussion
in the literature. One explanation is that this age is where most families look after children who
are more vulnerable to the effects of malaria than adults (Krupnick, 2007). Since the data on the
number of children per household is incomplete, we were unable to include more control variables
in the regression models, thus we cannot check for this.
Another new hypothesis is that altruistic policies are valued less than non-altruistic ones be-
cause of free-riding. The regression analysis supports this hypothesis, suggesting that altruistic
policies are treated more as public goods by the households. This result could also be due to
protest voters, since the household may be seeing community policies as the responsibility of the
government (Fonta et al. , 2010a). However, the protest zero rates are not explicitly reported in
all papers, thus we cannot check or control this possibility.
Health-state dependent expected utility theory implies that WTP should not change with
respect to an agent’s initial health status (Viscusi & Evans, 1990). In other words, pre and post
morbidity valuation should not be different from each other, because the sick state utility function
does not consider reference points to be important. Alternatively, prevention can be valued more
than treatment due to projection bias (Loewenstein et al. , 2003; Dolan & Kahneman, 2008).
Since we fail to find that treatment and prevention WTP’s are statistically different, our results
are supportive of the mainstream expected utility theory. However, since the households in these
studies are from malaria endemic areas, it is not unlikely that they have some idea of the discomforts
of malaria, hence have less projection bias. We cannot see what happens in non-malaria endemic
areas, since there are no studies conducted outside endemic areas.
Based on the mortality literature, WTP to avoid mortality risks can change with how much
perceived control the respondent has over the particular risk (Viscusi & Huber, 1987; Viscusi et al.
, 1991). We test this result in malaria morbidity valuation by looking for differences in WTP
between goods and services. The regression analysis fails to show consistent statistical significant
difference. It should be noted though that the mixed effects models show that goods are valued,
on average, more than services. However, this is not evident in the other regression specifications.
It is clear that this paper is not a reply to Trapero-Bertran et al. (2012). Though this previous
study provides a reference point, the approaches are fundamentally different. We compare results
across three different regression models, do a sensitivity check and a novel test of predictive power.
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Trapero-Bertran et al. (2012) considers one regression model and varies it by the number of
covariates. Their analysis is not carried further. Moreover, we are not able to replicate their
results, though the question of interest is identical. This is telling of how sensitive results are to
the dataset used in any empirical work, especially meta-analyses.
Finally, our conclusions and contributions are constrained in a number of ways. First of all, the
results here are valid for malaria endemic areas only. We can try to transfer these benefit values
to non-malaria endemic areas, but the prediction error is expected to be high. Another limitation
is that we do not have enough data from the papers to further explain our main results. We only
identify significant effects to mean WTP but are limited in explaining the channels through which
these effects occur. A clear example is age, where we have a consistent result but no clear channel.
Hence, the analysis here is open to extensions and improvements.
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A Appendix
Table A1: Contingent Valuation Main Elicitation Methods
Abbreviation Expansion Definition
OE Open Ended Question Respondents are asked what their maximum WTP is for the
given good or service in an open ended questions (Onwujekwe
& Uzochukwu, 2004).
PC Payment Card Respondents are given a card with various values on them, to
help them find and state their maximum WTP by circling the
relevant value (Masiye & Rehnberg, 2005).
SBDC Single Bounded Di-
chotomous Choice
Respondents are given a price value and are asked if they
are willing to pay this amount of money or not. They only
answer yes or no. After that, binary regression techniques
(logit, probit) are used to estimate a bid function from which
WTP is derived (Hanemann et al. , 1991).
SBDC + OE Single Bounded Di-
chotomous Choice +
Open Ended Question
SBDC with an open ended maximum WTP follow-up question
(Fonta et al. , 2010a).
DBDC Double Bounded Di-
chotomous Choice
Depending on the answer to the SBDC (yes or no), the re-
spondent is presented in the DBDC elicitation format either
a higher (if response to first bid was yes) or lower (if response
to first bid was no) value and asked if they are willing to pay
this amount of money. The sequence of WTP questions in
a DBDC elicitation format is also sometimes referred to as a
bidding game which can continue also to a third level.
BG Bidding Game Respondents are faced with a discrete price question. If they
answer yes, then the price increases and the same question
with the new price is asked. If they had answered no, then
the price decreases and the same question with the new price
is asked. Once the respondent answers yes/no after no/yes,
the price is assumed to be their maximum WTP (Mitchell,
1989).
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Figure 1: Age vs Mean WTP
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In the regressions, age enters as a linear and logarithmic term of the equation. In their review,
Krupnick (2007) concludes that age has a quadratic relationship with health valuation. The same
study also concludes that this captures the declining positive impact of age as one gets older. We
show the analytical differences of the impact of age with equations below. Hereon, Y denotes the
logarithm of mean WTP and X denotes age. Consider a quadratic specification, as concluded in
Krupnick (2007):
Y = α1X
2 + α2X
The impact of X on Y is given by the first derivative, 2α1X + α2. Prior evidence suggests that
this term should be positive, but diminishing as age increases. Therefore α2 is positive and α1 is
negative. The impact of increasing age is not expected to be negative, therefore the α1 term has
a small magnitude. This means that, with a small sample, α1 may not be detectable.
This motivates the introduction of the logarithmic term. The above equation now becomes, as
it is in our regressions
Y = α1log(X) + α2X
The impact of age is again given by the first derivative, α2 + α1
1
X . The term, α1
1
X , decreases in
magnitude as age increases. This means that the α2 value, in absolute terms, is larger. This makes
it more likely to be detected.
Indeed, this is what we find when the regressions are run with the quadratic and the linear +
logarithmic specifications. In the quadratic specification, both α1 and α2 are not significant, but
have the expected signs. In the linear + logarithmic specification, all coefficients are significant,
with the expected signs. A visual interpretation of the modeled relationship between age and mean
WTP can be found in Figure 1.
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Table A2: Studies Used in Meta-Analysis
Reference Country Elicitation Proce-
dure
Policy Type Good/Service
Adeneye et al. (2014) Nigeria SBDC Prevention Good
Alaii et al. (2003) Kenya OE Prevention Good
Aleme et al. (2014)∗ Ethiopia OE Prevention Good
Asafu-Adjaye & Dzator
(2003)∗
Ghana BG Insurance Service
Asante & Asenso-Okyere
(2003)
Ghana BG Prevention Service
Badjan (2011)∗ The Gambia BG Prevention Good
Bhatia & Fox-Rushby (2002) India BG Prevention Good
Bhatia (2005) India BG Prevention Good
Binam et al. (2004)∗ Cameroon BG Treatment Service
Chase et al. (2009) Mozambique BWFU Prevention Good
Cropper et al. (2004)∗ Ethiopia SBDC Prevention Good
Dupas (2014)∗ Kenya OE Prevention Good
Fonta et al. (2010b)∗ Cameroon SPC Prevention Service
Fonta et al. (2010a)∗ Cameroon SBDC+OE Prevention Service
Gebresilassie & Mariam
(2011)∗
Ethiopia BWFU Prevention Good
Gunasekaran et al. (2009) India OE Prevention Good
Guyatt et al. (2002) Kenya SBDC+OE Prevention Good
Hansen et al. (2013) Uganda BG+OE Detection Good
Hanson et al. (2005) Zambia Choice Experiment Treatment Service
Hoffmann et al. (2009)∗ Uganda Auction Prevention Good
Jima et al. (2005)∗ Ethiopia OE Prevention Good
Jimoh et al. (2007) Nigeria BWFU Treatment,
Prevention,
Eradication
Good, Service
Lin et al. (2000) Myanmar OE Prevention Good
Masiye & Rehnberg (2005)∗ Zambia PC Treatment Service
Mboera et al. (2014) Tanzania SBDC Prevention Service
Mills et al. (1994) The Gambia OE Prevention Good
Morey et al. (2003)∗ Nepal Not Specified Treatment Service
Mujinja et al. (2004) Tanzania SBDC+OE Prevention Good
Lertmaharit et al. (2000) Myanmar BG Detection Good
Okrah et al. (2002) Burkina Faso Not Specified Prevention Good
Onwujekwe et al. (2000) Nigeria BG, BWFU Prevention Good
Onwujekwe (2001) Nigeria BG, BWFU Prevention Good
Onwujekwe et al. (2001) Nigeria BG, BWFU Prevention Good
Onwujekwe & Nwagbo (2002) Nigeria BG Prevention Good
Onwujekwe et al. (2002) Nigeria OE Prevention Good
Onwujekwe et al. (2003)∗ Nigeria BG, BWFU, SH Prevention Good
Onwujekwe et al. (2004a) Nigeria Not Specified Prevention Good
Onwujekwe (2004)∗ Nigeria BG, BWFU, SH Prevention Good
Onwujekwe & Uzochukwu
(2004)∗
Nigeria OE, BWFU Prevention Good
Onwujekwe et al. (2004b)∗ Nigeria BG, SH Treatment Good
Onwujekwe et al. (2004c)∗ Nigeria BG, BWFU, SH Prevention Good
Onwujekwe et al. (2005a) Nigeria BG, BWFU, SH Prevention Good
Onwujekwe et al. (2005b)∗ Sudan BG Prevention Service
Onwujekwe et al. (2006)∗ Nigeria BG Treatment Service
Onwujekwe et al. (2007)∗ Nigeria BG Treatment Service
Onwujekwe et al. (2008)∗ Nigeria BG, BWFU, SH Prevention Good
Poulos (2000)∗ Tanzania SBDC Prevention Good
Prabhu (2010)∗ India SBDC Prevention Good
Rennie et al. (2009) Benin, Tanzania, Peru BG Detection Good
Sauerborn et al. (2005) Burkina Faso BG Prevention Good
Udezi et al. (2010)∗ Nigeria PC Prevention Good
Uzochukwu et al. (2010) Nigeria BG Detection Good
Weaver et al. (1993) Central African Re-
public
SBDC Treatment Good
Whittington et al. (2003) Mozambique SBDC Prevention Good
Wiseman et al. (2005) Tanzania BG Treatment Good
∗ denotes whether or not the study is in the 2-level mixed effects regression
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Table A3: Descriptive Statistics of Mean WTP
Weighted Unweighted
Mean WTP Lower CI Upper CI Mean WTP Lower CI Upper CI N
Private (Goods) 37.987 36.396 39.578 52.010 38.201 65.818 144
Public (Services) 26.121 24.712 27.530 164.413 -5.899 334.725 44
Treatment 32.224 28.148 36.301 160.148 -45.915 366.211 36
Altruistic 9.687 8.498 10.876 45.294 -22.149 112.738 23
Nigeria 47.586 44.067 51.104 51.756 35.742 67.770 97
Revealed Preferences 16.261 14.219 18.304 31.974 12.901 51.047 7
Zeros Included 37.997 35.808 40.186 66.175 43.853 88.497 138
One Off Payment 36.218 33.738 38.699 118.094 25.434 210.754 81
Monthly Payment 132.554 97.063 168.045 138.332 -2.471 279.135 11
3-Monthly Payment 4.383 2.498 6.268 4.803 2.638 6.969 7
Yearly Payment 36.159 34.328 38.283 40.480 33.245 47.714 89
Journal Publication 39.410 37.503 41.317 79.078 35.599 122.557 175
Technical Report Publication 34.093 18.981 49.205 95.371 -78.484 269.226 6
SBDC 358.921 231.940 485.902 177.763 94.629 260.896 19
SBDC + OE 9.955 3.601 16.309 9.955 5.278 14.631 8
OE 13.654 9.725 17.584 19.122 11.274 26.971 23
BG 34.044 30.805 37.283 41.135 30.516 51.755 89
DBDC 56.695 52.863 60.527 72.537 26.785 118.289 33
PC 3.016 2.334 3.699 179.544 -225.229 584.317 6
Not Specified 1.506 1.004 2.007 10.011 -8.958 28.980 6
Average Lower CI Upper CI N
Household Income 7710.058 4523.344 10896.77 114
Respondents’ Age 40.809 39.701 41.910 161
Nigeria 97
Ethiopia 13
Overall Mean WTP 39.509 37.680 41.339 78.317 37.671 118.963 188
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